Lung Institute in PA

Air Quality in PA

The American Lung Association recently released their 2015 State of the Air report listing the cities with the cleanest and most polluted air. Unfortunately for Pittsburgh, the city once again ranked among those with the most polluted air in the nation. With the combination of the pollution in the air, the high prevalence of lung disease in the area and the local steel mills and coal mines, many people believe that occupational lung disease in Pittsburgh is on the rise. However, help is on the way. Keep your eye out for the Lung Institute in PA in July of 2015.

What is Occupational Lung Disease?

Simplistically, occupational lung disease is a respiratory condition that develops due to polluted air in the workplace. This can include sand and dust particles, harsh chemicals, small metal particles, and in the case of black lung disease, coal dust. Most people assume that these lung diseases don’t develop unless there is some additional cause like smoking, or at the very least, that it takes years to come about. Unfortunately, this isn’t true. Around 19 percent of COPD cases are attributed to occupational lung disease and 31 percent of overall cases are found in people that never smoked. A history of exposure may be needed to develop a lung disease, but as early as the initial exposure, lung damage can occur.

Stem Cell Therapy

Many lung disease sufferers have opted for stem cell therapy to improve their lung function. While stem cell therapy isn’t a cure for lung disease, it has improved many patients’ quality of life. Everyone has stem cells in their bodies that act as our body’s system to promote healing. Stem cell therapy specifically targets damaged areas and accelerates the healing process. The Lung Institute uses a minimally invasive procedure that extracts stem cells from fat tissue, blood or bone marrow, and reintroduces them back into the body, targeting the damaged lung tissue. Stem cell therapy has significantly improved many patients’ lives by allowing them to breathe easier and do the things that they once enjoyed.

The Lung Institute is coming to PA

The Lung Institute has completed over 800 treatments in the past two years, and is expanding rapidly. They are looking forward to opening a new clinic in Pittsburgh in July 2015.

About the Staff

Dr. Jack Coleman, Jr., MD, will be the Medical Director of the Pittsburgh clinic. Dr. Coleman earned his medical degree from the University of Cincinnati. He later became an otolaryngology resident at the University of Pittsburgh Eye and Ear Hospital. He also served as a Lieutenant Commander and Commander in the United States Naval Reserve. Dr. Coleman is a diplomat of the National Board of Medical Examiners, is Board Certified in Otolaryngology and is a Fellow of the American Academy of Otolaryngology and Head and Neck Surgery. He is also a member of numerous medical societies including the American Medical Association, American Rhinologic Society, Association of Military Surgeons of the United States and the Pan-American Society of Otolaryngology. Along with his distinguished medical career, Dr. Coleman is a published author for several medical books and is referenced in numerous medical journals.

Although Pittsburgh has some of the highest levels of air pollution in the United States, there is hope for those suffering from COPD. The Lung Institute is on its way.

If you or a loved one suffers from chronic lung disease, contact the Lung Institute to find out if stem cell therapy can help get your life back within reach. Contact us by calling (800) 729-3065 to see if you qualify.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.